Brand Name | Status | Last Update |
---|---|---|
011054 niacinamide 4% / spironolactone 5% | unapproved drug other | 2020-07-02 |
011218 niacinamide 2% / spironolactone 5% / tretinoin 0.025% | unapproved drug other | 2020-07-02 |
011220 niacinamide 2% / spironolactone 5% / tretinoin 0.05% | unapproved drug other | 2020-07-02 |
011503 dapsone 6% / niacinamide 2% / spironolactone 5% | unapproved drug other | 2020-07-02 |
aldactone | New Drug Application | 2024-12-23 |
benzoyl peroxide 5% / clindamycin 1% / niacinamide 2% / spironolactone 2% | unapproved drug other | 2019-05-10 |
benzoyl peroxide 5% / clindamycin 1% / niacinamide 2% / spironolactone 2% / tretinoin 0.025% | unapproved drug other | 2019-05-03 |
benzoyl peroxide 5% / clindamycin 1% / niacinamide 2% / spironolactone 2% / tretinoin 0.05% | unapproved drug other | 2019-05-02 |
carospir | New Drug Application | 2024-04-12 |
clindamycin 1% / niacinamide 4% / spironolactone 2% / tretinoin 0.025% | unapproved drug other | 2020-06-04 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hypertension | D006973 | EFO_0000537 | I10 | — | — | — | 1 | 1 | 2 |
Hypercholesterolemia | D006937 | — | — | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Heart failure | D006333 | EFO_0003144 | I50 | — | — | 1 | — | — | 1 |
Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | — | — | 1 | — | — | 1 |
Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | — | — | 1 | — | — | 1 |
Glucose intolerance | D018149 | HP_0000833 | R73.03 | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 2 | — | — | — | — | 2 |
Diabetic nephropathies | D003928 | EFO_0000401 | — | 1 | — | — | — | — | 1 |
Kidney diseases | D007674 | EFO_0003086 | N08 | 1 | — | — | — | — | 1 |
Drug common name | Spironolactone |
INN | spironolactone |
Description | Spironolactone is a steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7. It has a role as a diuretic, an aldosterone antagonist, an antihypertensive agent, an environmental contaminant and a xenobiotic. It is a steroid lactone, an oxaspiro compound, a thioester and a 3-oxo-Delta(4) steroid. |
Classification | Small molecule |
Drug class | Antimineralocorticoid; Steroidal antiandrogen |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]34CCC(=O)O4)[C@@H]21 |
PDB | — |
CAS-ID | 52-01-7 |
RxCUI | — |
ChEMBL ID | CHEMBL1393 |
ChEBI ID | 9241 |
PubChem CID | 5833 |
DrugBank | DB00421 |
UNII ID | 27O7W4T232 (ChemIDplus, GSRS) |